Applied DNA Sciences, Inc. (NASDAQ:APDN) Short Interest Up 334.9% in June

Applied DNA Sciences, Inc. (NASDAQ:APDN) was the recipient of a significant increase in short interest in the month of June. As of June 15th, there was short interest totalling 784,200 shares, an increase of 334.9% from the May 31st total of 180,300 shares. Based on an average daily volume of 671,200 shares, the days-to-cover ratio is currently 1.2 days. Approximately 89.1% of the company’s shares are short sold.

Applied DNA Sciences Stock Down 0.6 %

APDN stock traded down $0.00 during trading hours on Thursday, hitting $0.41. 364,019 shares of the stock were exchanged, compared to its average volume of 360,248. The company has a 50-day simple moving average of $2.44 and a two-hundred day simple moving average of $8.11. Applied DNA Sciences has a 12 month low of $0.37 and a 12 month high of $37.20.

Applied DNA Sciences (NASDAQ:APDN) last issued its quarterly earnings data on Friday, May 10th. The technology company reported ($5.31) earnings per share for the quarter, missing the consensus estimate of ($4.60) by ($0.71). The business had revenue of $0.93 million during the quarter, compared to analyst estimates of $0.90 million. Applied DNA Sciences had a negative return on equity of 306.32% and a negative net margin of 222.33%. On average, equities analysts anticipate that Applied DNA Sciences will post -2.95 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on APDN. StockNews.com began coverage on Applied DNA Sciences in a research report on Friday, June 21st. They set a “sell” rating for the company. HC Wainwright reduced their price target on shares of Applied DNA Sciences from $7.00 to $1.50 and set a “buy” rating on the stock in a research report on Monday, June 10th.

Institutional Investors Weigh In On Applied DNA Sciences

A hedge fund recently bought a new stake in Applied DNA Sciences stock. Silverberg Bernstein Capital Management LLC acquired a new stake in Applied DNA Sciences, Inc. (NASDAQ:APDN) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm acquired 98,301 shares of the technology company’s stock, valued at approximately $61,000. Silverberg Bernstein Capital Management LLC owned about 0.72% of Applied DNA Sciences at the end of the most recent reporting period. Institutional investors own 22.22% of the company’s stock.

Applied DNA Sciences Company Profile

Applied DNA Sciences, Inc, a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services.